Angiogenin Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
| Angiogenin | |
|---|---|
| Protein Name | Angiogenin |
| Gene | ANG |
| UniProt ID | P03950 |
| PDB ID | 1B4I, 4JAE |
| Molecular Weight | 17 kDa |
| Subcellular Localization | Secreted, cytoplasmic, nuclear |
| Protein Family | RNase A family |
Angiogenin (ANG) is a 17 kDa secreted ribonuclease belonging to the RNase A superfamily. Originally discovered for its angiogenic properties, angiogenin has emerged as an important neuroprotective factor with roles in motor neuron survival and dopaminergic neuron protection. Mutations in the ANG gene cause autosomal dominant ALS, and common variants are associated with increased risk for Parkinson's disease. The protein exerts its neuroprotective effects through multiple mechanisms including promotion of ribosomal RNA biogenesis in the nucleus, activation of cell survival signaling pathways (PI3K/Akt and MAPK/ERK), and stimulation of neurite outgrowth. Therapeutic strategies under investigation include recombinant angiogenin protein supplementation, AAV-mediated gene delivery, and small molecule activators of angiogenin expression.
Angiogenin is a member of the RNase A superfamily with a characteristic RNase fold consisting of a small alpha-helix and three antiparallel beta-strands. The protein has ribonucleolytic activity but with much lower catalytic efficiency than RNase A. Importantly, angiogenin contains a nuclear localization signal (NLS) that allows it to translocate to the nucleus.
Angiogenin is a multifunctional protein with both angiogenic and neuroprotective properties:
Angiogenin functions through multiple mechanisms:
Angiogenin as biomarker:
| Application | Sample | Utility |
|---|---|---|
| ALS diagnosis | Blood/CSF | Elevated in ALS |
| AMD | Blood | Disease marker |
| Cancer | Blood | Angiogenesis marker |
Active research areas:
ANG mutations cause autosomal dominant ALS:
ANG variants are risk factors for PD:
| Variant | Disease | Mechanism |
|---|---|---|
| K17I | ALS/PD | Reduced neuroprotective activity |
| C39G | ALS | Impaired nuclear translocation |
| G88R | ALS | Decreased ribonucleolytic activity |
The study of Angiogenin Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.